• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Ophthalmology

Tailored care approaches may improve glaucoma medication adherence

byMolly Munsell
August 29, 2022
in 2 Minute Medicine, Chronic Disease, Ophthalmology
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In a meta-analysis of 19 randomized controlled trials, tailored care with and without additional interventions was associated with significant improvement in glaucoma medication adherence.

2. No adherence interventions, including tailored care, automatic reminders, or patient education, were associated with a significant decrease in intraocular pressure.

Evidence Rating Level: 2 (Good)

Study Rundown: Glaucoma is a chronic disease and a common cause of blindness. Prevention of vision loss requires consistent use of medications to lower intraocular pressure (IOP), which often involve regimens of multiple eye drops. This study aimed to analyze randomized controlled trials (RCTs) on interventions to improve glaucoma medication adherence using network meta-analysis. Across 19 included RCTs, nearly 5,000 patients were randomized to receive either standard of care or interventions such as extra communications and reminders, education, and incentives. Tailored care, or interventions individualized to patients, was found to have a 81.7% probability of benefit, tailored care plus multimedia education 84.6%, and tailored care combined with both multimedia education and a device reminder 87.3%. Among seven studies reporting IOP as an outcome, no interventions showed significant IOP benefit. Although different studies included patients at low risk versus high risk for medication non-adherence, this designation was not found to significantly alter results. The analyzed RCTs were highly heterogeneous, which limits interpretation of this data. A tailored care model, which includes needs assessment for each patient and creation of a personalized counseling, may be more difficult to scale than blanket interventions. However, this analysis indicates that the extra time and individualization may improve medication adherence, which is crucial for effective glaucoma treatment.

Click to read the study in Ophthalmology

Relevant Reading: Interventions to improve medication adherence: A review

RELATED REPORTS

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals

In-Depth [meta-analysis]: RCTs on adult patients with open angle glaucoma or ocular hypertension, defined as IOP above 21 mmHg, were included. Interventions were categorized into the following groups: short message service, telephone call, device reminder, motivational interview, multimedia education, physician education, provision of patient’s own medical records, incentives, tailored care, and brochures or leaflets. Study durations ranged from about one month to four years. All but two included studies had low or moderate risk of bias. The standardized mean difference for tailored care was 1.28 with a 95% confidence interval of 0.08-2.48. P-scores ranking interventions on a scale from 0 to 1 ranged from 0.914 for tailored care with multimedia education and device reminder to 0.230 for standard of care to 0.165 for motivational interviews. Probability of benefit statistics were calculated based on mean adherence scores derived from trial-designated adherence measurements. The I2 statistic was 90.9%, representing high heterogeneity.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adherenceglaucomaintraocular pressuremedication adherence
Previous Post

Aflibercept monotherapy equivalent to bevacizumab first for diabetic macular edema

Next Post

Increased breast cancer mortality observed in black women in the United States

RelatedReports

Medication adherence collage: a seven-day pill organizer, a folded paper pharmacy bag and a few coins
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Prescription medicines collage: a mortar and pestle, a blister pack of white tablets, teal capsules and a glass beaker
All Specialties

Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals

May 13, 2026
High blood pressure collage: a calm older woman behind a manual blood pressure cuff and bulb, with an artery cross-section
Cardiology

Intensive multifaceted management may improve blood pressure control among low-income patients

April 9, 2026
ADHD and blood pressure medicine collage: a smiling young woman with braids beside a round pill tin with a blank sticky note
Cardiology

Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy

February 27, 2026
Next Post

Increased breast cancer mortality observed in black women in the United States

Surgical reconstruction is superior to non-surgical rehabilitation for non-acute anterior cruciate ligament tears

Elevated NT-proBNP as a cardiovascular disease risk equivalent

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.